Prevalence of the overactive bladder syndrome by applying the International Continence Society definition.
about
Is the prevalence of overactive bladder overestimated? A population-based study in FinlandCombined conservative interventions for urge, stress or mixed incontinence in adultsReview of the epidemiology of overactive bladderSex differences in the brain: a whole body perspectiveOveractive bladder - 18 years - Part IThe impact of stress incontinence surgery on female sexual function.Epidemiology of lower urinary tract symptoms: emphasis on the status in Korea.Prevalence of overactive bladder, its under-diagnosis, and risk factors in a male urologic veterans population.Content validity and test-retest reliability of Patient Perception of Intensity of Urgency Scale (PPIUS) for overactive bladder.[Chronic pollakiuria: cystectomy or psychotherapy].Functional urological disorders: a sensitized defence response in the bladder-gut-brain axis.The prevalence and risk factors of overactive bladder symptoms and its relation to pelvic organ prolapse symptoms in a general female population.The relationship between irritable bowel syndrome, functional dyspepsia, chronic fatigue and overactive bladder syndrome: a controlled study 6 years after acute gastrointestinal infectionSacral neuromodulation and refractory overactive bladder: an emerging tool for an old problem.Cost implications of antimuscarinic drugs in the treatment of overactive bladder syndrome.Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions.Assessment of Proportion of Hidden Patients Having Symptoms of Overactive Bladder and Why Has It Been Hidden in Female Outpatients Admitted to HospitalTreating patients with overactive bladder syndrome with antimuscarinics: heart rate considerations.Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.Sex differences in the physiology and pharmacology of the lower urinary tract.Nocturia: a non-specific but important symptom of urological disease.Novel biomarkers for overactive bladder.Pharmacotherapy of overactive bladder: epidemiology and pathophysiology of overactive bladder.Overactive bladder in Taiwanese women: re-analysis of epidemiological database of community from 1999 to 2001.Prevalence, incidence and obstetric factors' impact on female urinary incontinence in Europe: a systematic review.Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms.Systematic literature review of clinical trials evaluating pharmacotherapy for overactive bladder in elderly patients: An assessment of trial quality.Potential Biomarkers Utilized to Define and Manage Overactive Bladder Syndrome.Older People's Preferences for Side Effects Associated with Antimuscarinic Treatments of Overactive Bladder: A Discrete-Choice Experiment.Urinary incontinence and quality of life among older community-dwelling Australian men: the CHAMP study.Botulinum Toxin A Intradetrusor Injection for Treating Neurogenic Detrusor Overactivity, A Single Centre Experience.Prospective study of prevalence of overactive bladder symptoms and child-bearing in women of reproductive age.A population-based survey of lower urinary tract symptoms (LUTS) and symptom-specific bother: results from the Brazilian LUTS epidemiology study (BLUES).Prevalence of painful bladder syndrome/interstitial cystitis-like symptoms in women: a population-based study in Korea.Prevalence of lower urinary tract symptoms, overactive bladder and urinary incontinence in western Turkey: results of a population-based survey.Lower urinary tract symptoms and urinary incontinence in a geriatric cohort - a population-based analysis.Transcutaneous electrical nerve stimulation: an effective treatment for refractory non-neurogenic overactive bladder syndrome?How important is the α1-adrenoceptor in primate and rodent proximal urethra? Sex differences in the contribution of α1-adrenoceptor to urethral contractility.OAB epidemiological survey of general gynaecology outpatients and its effects on patient quality of life.Efficacy and tolerability of solifenacin in men with overactive bladder: results of an observational study.
P2860
Q21144463-96D2896B-28A9-4BAF-BED4-1397E547F17DQ24236271-868CF27F-53FD-454E-9D3B-5454F8A0DAA3Q26746439-B8BC5A78-A6CD-4300-AE72-4FB36D259D23Q26798004-523233F3-71E9-4717-A6BB-2515095B95B6Q30388069-7AEB6CDE-994E-4539-BEB0-7C89C9EBCBDCQ30439610-9BE3CEEB-80D4-4BD4-95F1-F5D39033F7F2Q33633711-EDD530E6-0B69-4E6E-9FB5-49E2BCA39019Q34341969-224A9DA0-49A5-45E1-AA00-90427483F424Q34408830-1A5C8CFC-F612-48ED-B329-9A56A9C8DB4FQ34438162-FBBE3EAD-85AE-4E56-985C-6F27D346A077Q34546729-1CE5A168-3C71-45E9-9013-11CA906C43B3Q34771106-2E20B3BA-538C-4587-BBE9-379792D36978Q35658695-8AEAC7B1-3E7C-463D-BFA0-75D78D4760D6Q36099913-729E260B-696B-4E20-81BA-042917E8D1BFQ36428481-AD97008F-D1F9-4B8A-B7F4-7615299AC068Q36432096-FFA5A138-4836-4983-88CD-A7B441EA593FQ36760524-3D17AFDB-E108-4FA7-B0EF-04E013242995Q36964916-311523F2-6C3B-44F2-812A-4C91758BF509Q37075113-4E40DF34-3355-4526-911F-124BBE5E4007Q37198062-295FDDAA-3D15-4FA6-B703-ABBCA81A7A15Q37396037-4D3686A7-2C2D-4F3C-9513-2F0B1A231DC7Q37842130-784C1EC3-5C53-4597-9E26-0B514D0C1CCDQ37862738-08741FA1-CC75-4D17-BF7C-B5156D0BC110Q37914102-AE8CF2F7-FF2D-4E3E-8ED8-E9B67AF97D01Q38032429-50485E9C-4B4A-4C56-898B-D75D89A28EFFQ38071594-14298021-F3EA-4B06-85CB-02B7BE5F31CCQ38648674-04F65A2F-C637-4D37-8879-8831DD16229AQ38671606-56937BE4-3580-47BA-8EC2-4FEEE71FA60DQ38705836-70865F68-C245-461D-AFC5-41AFBBBD4321Q39925156-29B1C923-C0C0-407B-A3DF-D7538704442BQ40215511-6F9585D2-BA7B-4A73-9D0A-7DAA384885E9Q43495402-722E291A-6BDF-4E64-9735-A35136FEE4CBQ44015387-74F12AA0-B418-43B6-BCF2-26054782F728Q44190732-A153DA36-B57B-490D-A79B-41671B0AA02EQ44491882-4CCBB32B-8013-4C4A-98AD-2197D6FB4EFBQ44906735-38CD99C5-F1AB-4B03-9558-F04E2B3C27EDQ45167261-C20940D4-ABC8-435E-A474-D487503649F2Q47826780-EC36E30E-54BE-4E9A-A409-515F67DCAE17Q48062957-345810DD-9DC6-47D7-BD86-39FE3B32C8ABQ48150004-BBCACEAF-F17A-4435-9ECA-7DE9ADFEE4FA
P2860
Prevalence of the overactive bladder syndrome by applying the International Continence Society definition.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Prevalence of the overactive b ...... Continence Society definition.
@en
Prevalence of the overactive b ...... Continence Society definition.
@nl
type
label
Prevalence of the overactive b ...... Continence Society definition.
@en
Prevalence of the overactive b ...... Continence Society definition.
@nl
prefLabel
Prevalence of the overactive b ...... Continence Society definition.
@en
Prevalence of the overactive b ...... Continence Society definition.
@nl
P2093
P1433
P1476
Prevalence of the overactive b ...... Continence Society definition.
@en
P2093
Anton Ponholzer
Christian Temml
Stefan Heidler
Stephan Madersbacher
P304
P356
10.1016/J.EURURO.2005.04.026
P407
P577
2005-10-01T00:00:00Z